scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
2.615
-0.160 (-5.77%)
Mar 31, 2025, 3:11 PM EDT - Market open
scPharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 75.66 | 46.81 | 71.06 | 74.27 | 71.82 | Upgrade
|
| Short-Term Investments | 1.02 | 30.36 | 48.55 | 1.03 | 33.28 | Upgrade
|
| Cash & Short-Term Investments | 76.68 | 77.17 | 119.61 | 75.3 | 105.1 | Upgrade
|
| Cash Growth | -0.64% | -35.48% | 58.85% | -28.35% | 44.71% | Upgrade
|
| Accounts Receivable | 11.72 | 4.49 | - | - | - | Upgrade
|
| Receivables | 11.72 | 4.49 | - | - | - | Upgrade
|
| Inventory | 13.9 | 8.84 | 1.23 | - | - | Upgrade
|
| Prepaid Expenses | 3.55 | 2.44 | 2.28 | 2.79 | 2.61 | Upgrade
|
| Restricted Cash | - | - | 0.18 | 0.18 | - | Upgrade
|
| Other Current Assets | - | - | - | - | 0.12 | Upgrade
|
| Total Current Assets | 105.85 | 92.94 | 123.31 | 78.28 | 107.83 | Upgrade
|
| Property, Plant & Equipment | 1.33 | 1.46 | 0.62 | 0.48 | 0.91 | Upgrade
|
| Other Long-Term Assets | 0.34 | 0.08 | 0.27 | 0.28 | 0.31 | Upgrade
|
| Total Assets | 107.52 | 94.48 | 124.2 | 79.04 | 109.05 | Upgrade
|
| Accounts Payable | 3.88 | 4 | 1.52 | 0.54 | 1.67 | Upgrade
|
| Accrued Expenses | 9.73 | 8.75 | 5.29 | 3.99 | 4.75 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 9.81 | 2.41 | Upgrade
|
| Current Portion of Leases | 0.24 | 0.18 | 0.57 | 0.48 | 0.46 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.01 | 0.04 | Upgrade
|
| Other Current Liabilities | 1.02 | 0.21 | 0.04 | 0.03 | - | Upgrade
|
| Total Current Liabilities | 14.88 | 13.13 | 7.42 | 14.85 | 9.32 | Upgrade
|
| Long-Term Debt | 51.35 | 38.81 | 36.79 | 7.35 | 16.86 | Upgrade
|
| Long-Term Leases | 1.1 | 1.28 | 0.01 | - | 0.48 | Upgrade
|
| Other Long-Term Liabilities | 26.87 | 4.03 | 7.55 | 0.37 | 0.22 | Upgrade
|
| Total Liabilities | 94.2 | 57.26 | 51.76 | 22.57 | 26.88 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 379.81 | 318.56 | 298.93 | 246.17 | 243.83 | Upgrade
|
| Retained Earnings | -366.49 | -281.35 | -226.54 | -189.7 | -161.66 | Upgrade
|
| Comprehensive Income & Other | - | -0 | 0.03 | -0 | 0 | Upgrade
|
| Total Common Equity | 13.32 | 37.22 | 72.43 | 56.47 | 82.17 | Upgrade
|
| Shareholders' Equity | 13.32 | 37.22 | 72.43 | 56.47 | 82.17 | Upgrade
|
| Total Liabilities & Equity | 107.52 | 94.48 | 124.2 | 79.04 | 109.05 | Upgrade
|
| Total Debt | 52.69 | 40.27 | 37.37 | 17.64 | 20.21 | Upgrade
|
| Net Cash (Debt) | 23.98 | 36.9 | 82.25 | 57.67 | 84.89 | Upgrade
|
| Net Cash Growth | -35.01% | -55.13% | 42.62% | -32.07% | 64.53% | Upgrade
|
| Net Cash Per Share | 0.54 | 0.96 | 2.90 | 2.11 | 3.46 | Upgrade
|
| Filing Date Shares Outstanding | 50.28 | 36.05 | 35.77 | 27.37 | 27.36 | Upgrade
|
| Total Common Shares Outstanding | 50.1 | 35.97 | 34.26 | 27.37 | 27.33 | Upgrade
|
| Working Capital | 90.97 | 79.8 | 115.89 | 63.43 | 98.51 | Upgrade
|
| Book Value Per Share | 0.27 | 1.03 | 2.11 | 2.06 | 3.01 | Upgrade
|
| Tangible Book Value | 13.32 | 37.22 | 72.43 | 56.47 | 82.17 | Upgrade
|
| Tangible Book Value Per Share | 0.27 | 1.03 | 2.11 | 2.06 | 3.01 | Upgrade
|
| Machinery | 0.13 | 0.11 | 0.15 | 0.14 | 0.13 | Upgrade
|
| Leasehold Improvements | 0.01 | 0.01 | 0.1 | 0.1 | 0.1 | Upgrade
|
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.